InnovAge Holding Corp. (INNV) research
InnovAge Holding Corp.- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Last price
- $9.00
- As of
InnovAge Holding Corp. (INNV): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-K filed 2026-09-09.
As of . Source: SEC EDGAR filings for INNV. Method and limitations.
Share the INNV intelligence card
See INNV live in the terminal
Track INNV's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live INNV terminal, freeActive signals for INNV
- mediumEARNINGS_MISS
Q4-2026: Missed consensus by 19.8%, EPS $0.06 vs $0.0748 estimate
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 62% of INNV (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +572% to INNV (2026Q2)
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 62% of INNV (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +572% to INNV (2026Q2)
FREE, NO ACCOUNT
Every signal on INNV, as it fires
You are seeing 5 of 17 signals recorded on INNV since 2026-05-29.
The five above landed across 2 days. The other 12 were recorded on 3 other days. 11 of the 17 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in INNV (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 45784A104 · 2026Q2 | $3M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 45784A104 · 2026Q2 | $1.8M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 45784A104 · 2026Q2 | $1.4M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 45784A104 · 2026Q2 | $225K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, INNV
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
INNV against its peers
INNV's operating margin of 0.3% ranks in the 38th percentile of 16 Medical Care Facilities sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | INNV | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 990M USD | 1.4B USD | 42 | 17 |
| Gross margin | 23.0% | n/a | n/a | 4 |
| Operating margin | 0.3% | 3.7% | 38 | 16 |
| Net margin | -0.3% | 2.8% | 34 | 18 |
| Return on equity | -1.1% | 8.8% | 22 | 15 |
| P / E | n/a | 24.4x | n/a | 10 |
Peers (18): ARDT, AGL, NUTX, SGRY, ASTH, SNDA, ADUS, GRDN, NHC, TOI, CON, SRTA, MCTA, LFST, CYH, FMS, AIRS, JYNT. Left out: LTGHY (no annual filing), GMRS (no annual filing), BUHPY (no annual filing), AUNA (no annual filing), HWAIF (no annual filing), WW (no annual filing), PARK (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (INNV: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more INNV signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to INNVand get the insider, 13F, options, and confluence read in one view.